Acorah Software Products - Accounts Production 15.0.600 false true 30 November 2022 1 December 2021 false true No description of principal activity 1 December 2022 30 November 2023 30 November 2023 SC681715 Dr Hassan Baig iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure SC681715 2022-11-30 SC681715 2023-11-30 SC681715 2022-12-01 2023-11-30 SC681715 frs-core:CurrentFinancialInstruments 2023-11-30 SC681715 frs-bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 SC681715 frs-bus:FilletedAccounts 2022-12-01 2023-11-30 SC681715 frs-bus:Micro-entities 2022-12-01 2023-11-30 SC681715 frs-bus:AuditExempt-NoAccountantsReport 2022-12-01 2023-11-30 SC681715 frs-bus:Director1 2022-12-01 2023-11-30 SC681715 2021-11-30 SC681715 2022-11-30 SC681715 2021-12-01 2022-11-30 SC681715 frs-core:CurrentFinancialInstruments 2022-11-30
Registered number: SC681715
Hb Mediserve Limited
Unaudited Financial Statements
For The Year Ended 30 November 2023
Tyas Shaw & Co Limited
Balance Sheet
Registered number: SC681715
2023 2022
£ £
Current assets 7,040 7,040
Creditors: Amounts Falling Due Within One Year (1,695 ) (1,695 )
NET CURRENT ASSETS 5,345 5,345
TOTAL ASSETS LESS CURRENT LIABILITIES 5,345 5,345
NET ASSETS 5,345 5,345
CAPITAL AND RESERVES 5,345 5,345

Notes

1. General Information
Hb Mediserve Limited is a private company, limited by shares, incorporated in , registered number SC681715 . The registered office is 2 Clayhills Grove, Dundee, DD2 1NF.
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2022: 1)
1 1
For the year ending 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Dr Hassan Baig
Director
31/08/2024